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Abstract
The objective of this study was to compare the effectiveness of two compiled physiotherapy programs: one including forceful
traction mobilizations, the other including traction with unknown force, in patients with hip disability according to ICF (the
International Classification of Functioning, Disability and Health, 2001; WHO), using a block randomized, controlled trial
with two parallel treatment groups in a regular private outpatient physiotherapy practice. In the experimental group
(E; n 10) and control group (C; n 9), the mean (9SD) age for all participants was 59912 years. They were recruited
from outpatient physiotherapy clinics, had persistent pain located at the hip joint for  8 weeks and hip hypomobility. Both
groups received exercise, information and manual traction mobilization. In E, the traction force was progressed to 800 N,
whereas in C it was unknown. Major outcome measure was the median total change score ]20 points or ]50% of the
disease- and joint-specific Hip disability and Osteoarthritis Outcome Score (HOOS), compiled of Pain, Stiffness, Function
and Hip-related quality of life (ranging 0 100). The mean (range) treatments received were 13 (7 16) over 5 12 weeks and
20 (18 24) over 12 weeks for E and C, respectively. The experimental group showed superior clinical post-treatment effect
on HOOS (]20 points), in six of 10 participants compared with none of nine in the control group (p 0.011). The effect
size was 1.1. The results suggest that a compiled physiotherapy program including forceful traction mobilizations are short-
term effective in reducing self-rated hip disability in primary healthcare. The long-term effect is to be documented.
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Introduction
This article is about treatment of one group of
patients earlier characterized into two different
groups, namely (i) hip disability and (ii) hip osteoar-
thritis (OA). Disability serves as an umbrella term
for impairment, activity limitation and participation
restriction in the ICF (1). Patients with hip disability
have impairments that include pain, stiffness and
decreased joint mobility as part of the health domain
Body Functions (1). We found no prevalence data on
hip disability in PubMed, EMBASE or AMED, but
in Sweden in 2004, the prevalence of self-reported
hip disorders was 32% and increased with age from
18% among males from 38 to 47 years to 42%
among females from 48 to 67 years (2).
Also in Sweden, the age-specific prevalence of
X-ray verified hip OA is shown to fit an exponential
curve for which it increased from below 1% in the
age group B55 years to 10% in the age group  85
years (3). Specified, the prevalence of self-reported
hip OA in the Netherlands, defined as patients told
by their general practitioner as having this disease, is
about twice of that for X-ray verified hip OA (4).
The same study showed about half of those with the
disease to receive regular medication treatment.
In sum, patients in the combined group ‘‘hip OA
and hip disability’’ present a major health concern.
Hip disability is a closely related clinical category
to hip OA. The only difference in primary physician-
set diagnostics seems to be if there are joint space
narrowing (JSN) over 2.5 mm on X-ray pictures (4).
This differentiation seems odd, since most clinical
signs and symptoms have been found to be unrelated
to this degree of radiographic change (5). Further,
the validity of the much used American College of
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has been challenged, especially regarding direction
of limited range of motion (ROM) (8,9). Because
the two concepts overlap so strongly and because
physiotherapists intervene with the same approach
whether the patients have X-ray findings or not, we
choose to present epidemiology and treatment effect
data for both concepts in this introduction.
Clinically, hypomobility in individuals with painful
OA hips has sparsely been shown reversible by
exercise therapy (10 13), but recently, in a rando-
mized controlled trial (RCT), manipulations by
high-velocity small amplitude rotational thrust dur-
ing traction combined with self-stretching were
reported to improve ROM and disability better
than exercise therapy (14).
Joint mobilizations, defined as passive joint move-
ment with rhythm and grade such that the patient
can resist it (15), have until now shown no ther-
apeutic effect in patients with hip OA (16 19).
Traction as passive mobilization of 100 250 N has
documented negligible treatment effects in two
RCTs on ROM, pain, stiffness and function in
individuals with hip OA (16,17). Still, this treatment
in earlier textbooks was claimed to be highly effective
for hip pain (15,20,21). The discrepancy between
the research evidence and clinicians’ claimed experi-
ence might be due to non-adequate force-progres-
sion treating this massive joint in prior trials.
Traction forces of at least 400 600 N have been
shown necessary to deform the capsule into the
linear region of the load deformation curve in nine
of 12 healthy persons (21,22). Three persons even
needed higher forces. Although these data were
reported 16 years ago, they seem neither to have
reached the Norwegian manual therapy textbook
(23) nor Norwegian physiotherapy schools, accord-
ing to our knowledge.
We therefore undertook an RCT to compare the
effect of a compiled physiotherapy program includ-
ing manual traction mobilization graded up to 800 N
(21) with a compiled physiotherapy program includ-
ing traction mobilizations of unknown forces (23).
The latter is standard praxis being taught in Norwe-
gian physiotherapy schools for patients with hip
disability and hip OA. The upper force limit was
set due to our hypothesis that such traction forces
would deform the stiff hip joint capsule into the
linear region of the load deformation curve. Thus,
our treatment hypothesis was that patients who
receive a compiled physiotherapy treatment includ-
ing mobilization forces up to 800 N will experience
superior important clinical effects as compared with
those who receive a compiled physiotherapy treat-
ment with unknown traction forces.
Materials and methods
Study design
An RCT with two parallel treatment groups was
carried out. The treatment sequence was generated
by one of the authors (KV) using a block partition
method by a randomly numbered table (24). The
allocation concealment was realized by numbered
tickets in opaque envelopes sealed and shuffled into
an envelope containing one block sequence. The
block sizes were decided by the flip of a coin between
four and six. The total sequence was generated in
advance of patient enrolment for a total target
sample of 50 participants based on a power estimate
of 80%, using a nomogram (25), where the standar-
dized treatment difference was set to 0.80 for the
primary outcome and the a level to 0.05.
During enrolment, patients underwent a clinical
test procedure performed by KV. After signing an
informed consent, patients chose their own envel-
ope, signed it before opening and then signed the
allocation list. No efforts were made regarding
blinding of the therapists or patients.
Subjects
Candidates were men and women between 30 and
90 years referred to outpatient physiotherapy for hip
disability in Oslo County, Norway, from December
2003 to October 2004, who had: (i) persistent pain
in or from the hip daily in the last 8 weeks (26),
(ii) reduced hip mobility, defined as passive ROM
less than two standard deviations (SD) of the
reported mean active ROM for their age group in
at least one direction on the painful side (27), and
(iii) pain located toward the hip joint when tested by
passive firm end-pressure in orthogonal plane move-
ments. Point (ii) was estimated by KV during the
clinical examination, while (iii) was ensured by the
patients pointing directly at the inguinal crease as the
tests were performed.
Patients were excluded if they had: (i) history or
signs in accordance with labral injury and, or a free
intra-articular body, (ii) trauma, deformity or OA
due to early hip disease, (iii) medically diagnosed
inflammatory disease, (iv) showed obvious neurolo-
gical signs such as sensory or motor paralysis,
(v) other diseases, which entailed a powerful con-
straint on the physical, psychological or social
functioning, (vi) additional pain from the lower
back, pelvis, knee and/or ankle, which overshadowed
pain from the hip, (vii) problems receiving informa-
tion due to inadequate hearing, sight, intellect or
knowledge in the Norwegian language, (viii) fulfilled
criteria for total hip replacement (28). All phy-
siotherapists (n 556) and primary physicians
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Service to work in Oslo County received a written
invitation to refer patients to the project. This gave
very few volunteers, and nearly all participants were
recruited by KV from the waiting lists of four
physiotherapy clinics. General practitioners referred
two patients.
Point (vi) was evaluated by repetitive stress tests
directed sequentially to the lower back, pelvis and
hip joint. The patients were simultaneously urged to
express which test was most provocative and whether
it reproduced their usual pain. They were asked to
locate the pain using one finger. KV based his
evaluation on the patients’ expressions held together
with information of which joints received the main
joint stress at the given point of expression. The
pelvic joint was stressed directly according to Hesch
(29). The lumbar spine was stressed through neu-
rodynamic tests (30) and by direct posteroanterior
springing tests to the segments while lying prone. KV
added countertorques to confine the joint reaction
forces in the joints being tested. For instance, when
stressing the hip joint, contertorques around the
sacroiliac axis were added to the torques caused by
movement of the femur. One practical example: with
the patient lying prone, posteroanterior pressure was
added to the tuber ischii while extending the hip. In
all tests, the force progression principle (31) was
used, starting at the painless side or level. Each
clinical examination took approximately 2 h, the
anamnesis included. A flow diagram of the progress
of the trial is shown in Figure 1.
Interventions
In the experimental group, all treatment was per-
formed in one clinic by two physiotherapists who
had over 10 years of experience with this method
(21) and this group of patients. The last month
before the trial, the therapists once daily calibrated
their force effort during traction by applying forces
to a model of a foot connected to a hanging scale,
which again was connected to the bench. This was
also done once weekly during the trial. When
blindfolded, the therapists applied forces within an
accuracy of 50 N in the trial period.
The mobilization technique of Samuelsen &
Høiseth (21) was carried out with the patient lying
supine on the left-hand side of the plinth (while
treating the right side), at first with the hip in the
maximal loosely packed position (23), which has
been shown to facilitate joint separation (22). When
joint stiffness in this position decreased, as judged
by the therapist, traction was performed with the
joint pre-positioned in the hypomobile direction
(Figure 2). Each patient received about 15 min of
manual traction mobilization in each session, graded
according to Maitland (15). The average holding
time in the first sessions varied from 20 to 40 s,
and decreased to 10 15 s as the therapists judged
improvement of the joint’s elasticity.
The therapists in the experimental group also used
deep soft-tissue techniques (32), strength exercises,
and self-stretching (33,34)   targeting trigger points,
weak muscles and stiff muscles, respectively. One
strength exercise has been specially designed to
target the m. quadriceps coxae   comprising mm.
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Figure 1. The progress of the participants through the trial
phases. Not meeting inclusion criteria due to: lumbar pain
(n 6), pelvic pain (n 4), enthesopathies without joint pain
(n 7), too small ROM deﬁcits (n 3). The one dropout was
given the median change score for his group, implementing the
intention-to-treat analysis, which explains why there was data for
nine participants being analyzed in the control group.
Manual traction mobilization of the hip 119piriformis, gemellii and obturator internus: The
patient horizontally abducts the 908 flexed hip joint
lying on his/her side or in the so-called ‘‘three
extremity standing’’ position. The lever arm is
adapted by changing the knee angle or the patient’s
position in the gravity field. Furthermore, the
therapist stretch the same joint near muscle group
by combining hip flexion, adduction and external
rotation, as this has been shown in cadavers to
lengthen the muscles more than doing the intuitive
hip internal rotation in combination with the two
other motions (35). The information (28), given in a
pamphlet, encouraged among other things taking
out full ROM daily, sitting for a maximum of 20 min
continuously without movement and doing varied
low-impact activities regularly.
In the control group, the participants were treated
in six clinics by eight physiotherapists, of whom three
were licensed specialists in manipulative therapy.
The therapists had used the standard manual trac-
tion mobilization technique (23) on a regular basis,
and had at least 5 years of clinical experience.
Mobilizations (23) were performed without standar-
dization of applied forces, and therapists were urged
to perform treatment as normal. The patients
received information, exercises and soft-tissue tech-
niques governed individually by each therapist. KV
asked for the therapists’ clinical experience, on the
telephone before the trial, and received treatment
reports for all but one patient after the trial. The
information lacking was obtained by telephone.
In both groups, patients with bilateral problems
received treatment on both sides, giving a maximum
of 10 min of mobilization for each hip. Patients
received soft-tissue techniques, exercises and infor-
mation for which no restrictions were imposed by the
trial administrator. Other treatment modalities were
discouraged during the treatment period. No effort
was made to control compliance regarding home
exercises. The trial protocol stated two treatment
sessions per week over 12 weeks in both groups (see
results). Each treatment session lasted 30 minutes in
total.
One patient in the control group received a co-
intervention of therapeutic low-intensity ultrasound.
No participants in either group withdrew because
of increased complaints, nor received therapy from
other health professionals. Neither was there re-
ported any adverse effects.
Procedures
Before the enrolment, all participants completed a
questionnaire regarding demographic variables, pre-
vious complaint(s), duration of symptoms, co-inter-
ventions and previous treatment with manual
traction mobilization. The patients were recorded
to have radiographic hip OA when showing positive
X-ray reports and stating to have received hip OA
diagnoses orally from their general practitioners.
The use of non-steroidal anti-inflammatory drugs
(NSAIDs) and analgesics were permitted as needed
Figure 2. Physiotherapist mobilizing in traction on the patient’s right hip. The pillow bolsters the pubic and the anterior superior iliac
spines. The belt resisting lateral pelvis glide loops the metal under the patients left side of the plinth, and turns around the pelvis in a level
directly inferior to the two anterior superior iliac spines to reconnect. Pelvis caudal glide is resisted by a belt looped from under the superior
right-hand side of the plinth, turn around the ipsilateral pubic bone to recouple.
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0) and at follow-up (week 12). The self-rating
questionnaires were filled in at home after the
clinical examination. The patients with bilateral hip
disability were encouraged to refer to their general
situation considering both hips when reporting pain
and stiffness.
Outcome assessment
The main outcome variable was the median total
change score of the patient self-reporting question-
naire Hip disability and Osteoarthritis Outcome
Score (HOOS) (36), as stated in the trial protocol
to the Regional Ethics Committee (for cut-off
values, see statistics). The HOOS comprises five
subscales and 39 items; each item has five alter-
natives scored from 0 to 4. The total median HOOS
(HOOSt) was calculated adding the five 0 100
scaled subscales and dividing them by 5. The
subscales of HOOS represent secondary outcome
variables (Table I).
The Swedish version LK1.1 of the HOOS has
been validated for patients with hip disability and hip
OA (36,37), and it was translated into Norwegian
through an ethnocentric approach (38). The scale
was first translated from Swedish to Norwegian by
the second author (EL), who is native Norwegian
with a thorough knowledge of the Swedish language.
The EL-version was then translated back to Swedish
by OB (see acknowledgement), a Swedish Master of
Science colleague, who at that time had lived for
5 years in Norway. The three different versions   the
original LK1.1 and the two translations   were then
compared by KV. Two items were dissimilar in the
two Swedish versions. The developer of the scale
(39) was consulted, before KV and the two transla-
tors discussed the items and reached a consensus.
The Norwegian version is now electronically avail-
able (40) and is currently being further evaluated at
our university.
Secondary outcome measurements of passive
ROM were taken using a goniometer with a scale
marked in 58 increments as prior validated (41). The
two raters, 3rd-year physiotherapy students, were
trained in a protocol adapted from Norkin & White
(42). We adapted the rotations to be taken with the
patient sitting instead of prone. This skill acquisition
was guided by KV for 9 h in the month before
baseline. The protocol was tested and found unreli-
able according to the requested minimal clinical
important difference of 58 in each direction. The
test retest procedure, results and discussion have
been reported earlier (43). Because of the inade-
quate reliability of the tests, the ROM results are not
presented in this article.
Data analysis
Analysis was performed according to the intention-
to-treat principle (44). The only patient who
dropped out was given the median change scores
for the rest of the control group to which he
belonged (Table I).
A null hypothesis of no clinical difference in
HOOS between the two treatment groups was
expressed against the alternative hypothesis that the
experimental group would gain superior clinical
improvement. Descriptive measurements of the
change scores within and between groups were in
medians, interqartile ranges (IQR) and percentages.
The differences between the groups were tested by
the Mann Whitney U-test, presented with p-values
and non-parametric confidence intervals (CI) (45).
Specified, the non-parametric 95% CIs were calcu-
lated by:
K Wa=2 
n(n   1)
2
where Wa/2 is 100a/2 percentile of the distribution of
the Mann Whitney test statistics. The Kth smallest
to the Kth largest of the n m differences then
determine the 100(1 a)% CI. Values of K
for finding approximate 95% CI were taken from
a table according to the size of n ( number
of patients in the experimental group) and m
( number of patients in the control group).
The group differences in proportions were tested
for significance by Fisher’s Exact Test. Cutpoints for
clinical improvement were set to a change of ]20
points (absolute criteria) and ]50% (relative cri-
teria), and dichotomized participants into respon-
ders and non-responders (46). Odds ratios (OR)
with confidence limits were calculated by exact
methods (StatXact) and interpreted by the scale of
Hopkins (47). Effect size (ES) for the HOOS data
were calculated as the fraction of median difference
and IQR for the change scores of the total sample
(48), in mathematical form [(DE DC)/IQRpooled],
where D change score, E experimental group,
C control group and IQR interquartile range.
These ESs were interpreted according to the scale
of Cohen (49): trivial (B0.2), small (]0.2B0.5),
moderate (]0.5B0.8) or large (]0.8).
For all analyses, statistical significance was consid-
eredatatwo-tailedlevel 55%.The calculationswere
done on a personal computer using SPSS 12.0†
(SPSS Incorporated), Excel 2002† (Microsoft Cor-
poration) and Statxact 5† (CYTEL Software).
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The study protocol was recommended by the
Regional Committee for Medical Research Ethics,
Western Norway (study no. 218.03) and approved
by the Norwegian Social Science Data Service. It
was conducted in accordance with the Declaration of
Helsinki of 1975, as amended in 2000. Written and
oral informed consents were obtained from all
patients before inclusion.
Results
Subject characteristics
Small differences were seen at baseline between the
two groups (Table I). However, the experimental
group had more females, more bilateral hip pain,
longer duration of pain and further distal pain
irradiating.
The median, IQR and range of treatment sessions
accomplished were 13.5, 5, 7 16 and 20, 6, 13 24
for the experiment and control groups, respectively
(p 0.007). There was negligible difference between
groups in number of participants using analgesics
and NSAIDs, both at baseline and follow-up (results
not shown).
Outcomes
At follow-up, all participants in the experimental
group reported reduced disability in total HOOS
compared with baseline (Table II). In the control
group, four participants expressed deterioration and
five improvements.
In the total HOOS, there was a statistically
significant difference in favour of the experimental
group. This difference was also seen in three of five
subscales (Table III). The within-group difference in
total HOOS was a 43% and 3% improvement in the
experiment and the control groups, respectively
Table II. Raw scores in total HOOS for individual participants (P), given in medians at baseline (week 0) and follow-up (week 12).
Experimental group (n 10) Control group (n 9)
P Baseline Follow-up Change P Baseline Follow-up Change
E1 43 14  29 C1 73 58  15
E2 65 58  7C 2 3 8 3 6  2
E3 23 11  12 C3 65 63  2
E4 48 26  22 C4* 45 37  8
E5 63 36  27 C5 53 34  19
E6 36 31  5C 6 4 2 5 2 1 0
E7 43 19  24 C7 60 64 4
E8 56 34  22 C8 35 44 9
E9 56 52  4C 9 6 0 6 9 9
E10 48 14  34
The scale is graded 0 100, best to worst. Negative change scores express improvement. *The participant given the group median change
score. There are nine participants analyzed in the control group because the follow-up value for the one who dropped out was filled in by the
analyzer according to the intention-to-treat principle. Total HOOS, Hip disability and Osteoarthritis Outcome Score HOOS [(S5HOOS
subscores)/5]; E1, experimental group participant one; C1, control group participant one.
Table I. Baseline characteristics of all participants (n 19) includ-
ing the total Hip disability and Osteoarthritis Outcome Score
(HOOS) and subscales in medians and interquartile range (IQR),
if not otherwise speciﬁed.
Variables
Experimental
group (n 10)
Control group
(n 9)
Demographics
Age, years, mean (SD) 62 (14) 57 (21)
Body mass index, kg/m
2,
mean (SD)
24 (4) 25 (7)
Gender, n, females 6 2
Prognostic characteristics
Duration of complaints,
years, mean (SD)
10 (6) 5 (9)
Distal spread of pain, n
Nates, thigh, calf, foot 1, 2, 2, 5 1, 5, 1, 2
Hip pain, n
Uni, bilateral 4, 6 6, 3
Hard physical work
which aggravates
condition
44
OA, X-ray verified, n 87
HOOS
Stiffness
a 43 (21) 55 (25)
Pain 46 (28) 44 (19)
ADL
b 38 (28) 41 (19)
R&S
c 63 (31) 56 (22)
HR-QL
d 59 (16) 63 (34)
Total HOOS
e 48 (17) 53 (23)
aSymptoms other, included stiffness;
bActivity limitation in daily
living;
cActivity limitation in recreation and sports;
dHip-related
quality of life;
eTotal Hip disability and Osteoarthritis Outcome
Score HOOS [(S5HOOS subscores)/5], Scores: 0 (no dis-
ability) 100 (worst possible disability). SD, standard deviation.
122 K. Vaarbakken & A. E. Ljunggren(results not shown). In Pain, the same figures were
63% and 25%, respectively.
Judged by the absolute criterion in the main
outcome total HOOS, more patients responded in
the experimental group (six of 10) than in the
control group (none of 9), a difference that was
statistically significant (Table IV). Also by the
relative criterion in the total HOOS, more patients
responded in the experimental than in the control
group, but the difference was not statistically sig-
nificant.
In subscales, by both absolute and relative criteria,
more participants responded in the experimental
than the control group in all but Hip-related quality
of life (HR-QL) (Table IV). Only in Pain was the
difference statistically significant. The number of
patients responding in HR-QL by the absolute
criterion was higher in the control group, whereas
by the relative criterion there was equality amongst
the groups. The effect magnitude in Pain by OR was
very large by the relative criterion (Table IV).
All ESs were in favour of the experimental group
(Table V). The ESs were large in total HOOS, as
well as in the subscales Symptoms others including
stiffness (Stiffness), Activity limitation in daily living
(ADL), and Activity limitation in recreation and
sport (R&S). In the subscales Pain and HR-QL, the
ESs were moderate.
Discussion
The participants with hip disability who received a
compiled physiotherapy program including graded
traction mobilization up to 800 N reported statisti-
cally significant and superior important clinical
effects in total HOOS and Pain after 12 weeks
compared with the control participants who received
a compiled physiotherapy program including
Table III. Between-group comparisons in total HOOSt and in subscales.
Variables Group Baseline Follow-up BGD (CI) p-values
HOOSt E 48 (17) 29 (26)
C 53 (23) 48 (26)  20 ( 6, 31) 0.001*
Stiffness E 43 (21) 25 (24)
C 55 (25) 55 (30)  15 ( 6, 25) 0.005*
Pain E 46 (28) 17 (14)
C 44 (19) 33 (13)  18 ( 6,  32) 0.067
ADL E 38 (28) 19 (33)
C 41 (18) 37 (22)  21 ( 2, 21) 0.045*
R&S E 63 (31) 25 (39)
C 56 (22) 59 (25)  31 ( 15, 50) 0.045*
HR-QL E 59 (16) 47 (31)
C 63 (54) 63 (30)  13 (6, 25) 0.24
Absolute values are given in medians and interquartile range. The experimental group (n 10) and the control group (n 9). Baseline test
(week 0), follow-up test (week 12), BGD, between-group difference; CI, 95% confidence interval; E, experiment; C, control. Significance
tested by Mann Whitney U-test. HOOSt, median total Hip disability and Osteoarthritis Outcome Score [(S5HOOS subscores)/5];
Stiffness, Symptoms others including stiffness; ADL, Activity limitation in daily living; R&S, Activity limitation in recreation and sport;
HR-QL, Hip-related quality of life. *Statistical significant difference (a50.05). Scores: 0 (no disability) 100 (worst possible disability).
Table IV. Participants dichotomized into responders and non-responders according to scores on total HOOS and its subscales.
t-HOOS Stiffness Pain ADL R&S HR-QL
Improvement ]20 points
No responders (E, C) 6, 0 4, 0 7, 2 3, 0 7, 2 1, 2
p-values 0.002* 0.087 0.07 0.211 0.07 0.058
Odds ratio inf   8.2   8.2 0.39
(95% CI) 1,6-inf$ 0.75 113 0.75 113 0.006 9.4
Improvement ]50%
No of responders (E, C) 4, 0 5, 0 8, 1 5, 1 6, 1 0, 0
p-values 0.087 0.057 0.005* 0.141 0.057  
Odds ratio    32.0 8.0 12.0  
(95% CI) 1.8 1590 0.56 425 0.83 619
Experimental (E) group (n 10) and control (C) group (n 9), tested for statistical significance by Fisher’s exact test. $The exact lower
confidence limit for odds ratio. Inf, infinity; t-HOOS, the total Hip disability and Osteoarthritis Outcome Score [(S5HOOS subscores)/5],
Scores: 0 (no disability) 100 (worst possible disability); Stiffness, Symptoms others including stiffness; ADL, Activity limitation in daily
living; R&S, Activity limitation in recreation and sport; HR-QL, Hip-related quality of life. *Statistically significant difference (a55%). CI,
confidence interval.
Manual traction mobilization of the hip 123unknown traction forces. The number of treatments
used in the forceful mobilization group was 33% less
then in the standard treatment group.
The therapists performed fewer treatments over a
shorter period than stated in the protocol. They
explained this as a deliberate judgment related to
assessed normalized accessory hip motion, and the
patient’s describing satisfactory symptom reduction.
The therapists seem to have violated the study
protocol in the best interest of their patients. If the
trial protocol had criteria for ending treatment as
patients reduced symptoms under a certain limit, the
ethical standard of the trial might have been im-
proved. This would have required follow-up tests
with closer intervals, which might had given data
regarding the onset of the experimental treatment
effect. However, it is plausible that the differences in
outcome might have been even larger if the thera-
pists had strictly complied with the trial protocol, as
it is unknown if the effect of forceful traction follows
an increase in capsular elasticity. Change in symp-
toms and accessory motion due to traction mobiliza-
tion alone is to be scrutinized.
This trial presents only short-term results. The
long-term effect ought to be assessed, considering
the large ESs seen. We suggest that treatment effects
of all the modalities in the experimental group
should be further scrutinized.
The small number of participants in the final trial
makes it necessary to interpret the results with
caution. The a priori set power of 80% required a
standardized treatment difference of 80% for the
primary outcome. However, the larger treatment
difference actually seen still afforded adequate power
for total HOOS and Pain.
There might be several reasons why only 19
patients were enrolled in the inclusion period.
Simultaneously to this trial, two other research
groups were recruiting patients with nearly identical
inclusion criteria in Oslo County. In addition, all
patients with hip OA in Norway are entitled to
physiotherapy free of charge from our National
Health Service. Several physiotherapists stated
frankly that treating these patients was a source of
steady income. By participating in the trail, they
would risk losing them to another clinic. We
hypothesize economic and strategic reasons also to
have influenced the general practitioners, as they
tend to ignore evidence-based non-medical treat-
ment for hip OA patients (50). KV visited 24 of the
largest clinics, in both medicine and physiotherapy,
presenting the trial and its importance. Nevertheless,
no more than four physiotherapy clinics would
commit to letting us mail information to patients
on their waiting list.
Force difference in traction mobilization is not the
only cause of the effect in this trial. There was
suboptimal control regarding the additional treat-
ment performed in the two groups. One experiment
therapist has developed specialized exercises   both
for strengthening and stretching   targeting the
small external rotators of the hip in particular
(33,34). Both experimental therapists worked by
his principles. The result then might as likely be
caused by these exercises as by the forceful mobiliza-
tions. On the other hand, it might seem unlikely that
these exercises should be twice as effective as
exercises used in other trials (51). In addition,
testing the effect of mobilization without other
treatment modalities might be invalid, as manual
therapy is seen as only one remedial action of several
building the total care (52). Still, our hypothesis is
that forceful mobilization has important clinical
value for hip disability even as a single modality.
The therapists performing the experimental treat-
ment might have been better craftsmen than those in
the control group. If the same therapists were to treat
both groups, these personal factors could have been
better controlled. On the other hand, this might have
affected the therapist’s belief in the treatment, and
thus lowered the placebo effect in the control group.
This might also have led to (patient) biasing inter-
group contacts. As forceful traction mobilization
feels quite different from low-force mobilization,
the result might have been a lowered placebo effect
in the control group related to decreased therapists’
and patients’ expectations.
The reliability of force application might have
been more closely examined. However, serious
efforts were made to standardize the force applica-
tion in the experimental group. The therapists
used clinic-like procedures regarding accuracy and
time efforts in both groups, which made the inter-
ventions easily applicable in a private practice
Table V. Effect sizes for total HOOS and its subscales.
Total HOOS Stiffness Pain ADL R&S HR-QL
Pooled variability 21 15 31 15 34 25
Effect size 1.1 1.0 0.7 0.8 1.0 0.6
Pooled variability of both experimental and control group. HOOS, Hip disability and Osteoarthritis Outcome Score HOOS [(S5HOOS
subscores)/5]; Stiffness, Symptoms others including stiffness; ADL, Activity limitation in daily living; R&S, Activity limitation in recreation
and sport; HR-QL, Hip-related quality of life. Confidence intervals lacking due to non-parametric statistical tests.
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increased the generalization of the result. Imposing
extra effort on the control therapists made it harder
to recruit patients. This is the reason the force used
in the control group was unknown, i.e. it reflects
standard practice.
In this study, only the data puncher and the ROM
raters were blinded. The trial administrator, KV, was
blinded to all but the last patient in each randomiza-
tion block, but should have been totally blinded.
Not blinding the patients made them prone to
bias, by their own and therapists’ outcome expecta-
tions. Still, according to the scale afforded by
Jadad et al. (53), we rated the trial quality to be
3/5 points.
The present data has raised suspicion against the
responsiveness of one of the items in the subscale
HR-QL: ‘‘How often do you think about your hip?’’,
since only one out of 19 participants reported to
have changed their frequency of thinking. Maybe the
question rather should be: ‘‘How often do you have
negative thoughts about your hip?’’ The young
HOOS scale needs further testing (36).
The main outcome measure might rather have
been function and pain, as recommended by the
Osteoarthritis Research Society International for OA
clinical trials (46). This would have facilitated the
direct comparison with earlier trials. Still, the multi-
factor total HOOS score might give even a more
informative picture of the health problems experi-
enced by these patients.
The HOOS is an ordinal scale. Statistical methods
for data from rating scales is said to differ completely
from traditional methods for quantitative variables,
since calculations based on adding or subtracting
ordinal data are not appropriate (54). On the other
hand, others find that parametric methods can also
be used for ranked data (55). We choose to calculate
median change scores even though the data are on
an ordinal scale level.
We unwarily used a different method for calculat-
ing the total HOOS scores from the one prior
validated. The validated method is to sum all the
raw scores, divide them by 5 and then multiply by
100. The effect of not using this method is that the
subscales with fewer items gain more weight on
HOOS. Stiffness and HR-QL are the subscales with
the fewest items, and, as the ESs were large and
moderate in Stiffness and HR-QL, respectively, this
might not be seen as a threat to the validity of our
calculations. This was supported by our recalcula-
tion of total HOOS. Our re-analysis showed the
same statistically significant between-group differ-
ence as before.
This study is the first RCT to show clinically
important statistically significant treatment out-
comes related to a compiled physiotherapy program
including forceful manual traction mobilization in
patients with hip disability. This supports the hy-
pothesis of inadequate use of force progression in
prior mobilization trials (16,17).
The subjects included displayed equality on most
baseline factors, which is considered to strengthen
the results (25). The ES seen in this trial is 2 4 times
larger than reported in hip OA information trials
(28) and exercise trials (56). Hence, this might
support the hypothesized causation of the forceful
traction mobilizations. Notwithstanding, the effect
of the compiled approach is consistent.
The manual traction mobilizations method of
Samuelsen & Høiseth (21) might be regarded a
highly effort-demanding approach. However, in
support of the feasibility of the method, normally
strong female 50-year-old physiotherapists are fully
capable of handling this force, as documented by
measurements taken with our hanging scale arrange-
ment.
To take out the 1 1.5 cm of accessory motion of
the hip by traction, forces amounting at least 400 
600 N are probably required (21,22). Prior to the
trial, we made an experiment using the technique
applied in the control group (23), which showed the
bench moving forward on the floor before the scale
showed 350 N. This force was applied to a model of
a foot, tied to a hanging scale, again fixed to a regular
heavy therapy bench with a person weighting 770 N
on top. The bench was placed on wood with a floor
sealer and floor covering, but the results were
similar. It therefore seems that either external or
therapist fixation of the plinth is a presupposition for
effective hip mobilizations.
A recent review on exercise treatment for hip OA
(51) included only two high-quality studies. Both
studies reported small to moderate ESs regarding
pain and function, respectively. According to the
much larger ESs seen in the present study, exercise
therapy is suggested only as a supplement to forceful
traction mobilization treatment and manipulations
(14) in patients with hip disability.
For improving function and ROM in even more
hypomobile patients than in this trial, like those
reported in the study of Hoeksma et al. (14), forceful
abrupt traction and rotational manipulations might
be the first line of treatment. This is derived from the
fact that our most reliable ROM measures (43)
showed minimal change after treatment, whereas
Hoeksma et al. (14) reported great increase in ROM
in most participants. Nevertheless, our measure-
ments were unreliable, and we also have to question
data reported from other researchers (13,14), as
they did not report absolute reliability values. In
sum, knowledge about the effect of both forceful
Manual traction mobilization of the hip 125mobilization and manipulation on ROM is uncer-
tain. The frequency and force needed to achieve hip
joint hysteresis by traction mobilization warrants
further investigations. The fact that two raters,
even though they were still students, were not able
to reliably measure ROM, makes it reasonable to
question also the reliability of KV’s estimates when
testing the participants for eligibility. In future trials,
cinematographic evaluation of hip ROM might be
needed to accurately secure the hypomobility criteria
(57). By such technology, it should be possible to
answer the effect of manual physiotherapy interven-
tions on ROM in these patients.
NSAIDs are highly recommended by general
practitioners as a treatment for lower limb OA
(58), even though there are few studies of adequate
quality giving explicit data regarding treatment in
hip OA (58 61), and the extracted ESs regarding
pain and function are reported to be small (0.2 0.3)
compared with placebo treatment (58). The present
trial showed 3 4 times larger ESs than this and even
had an active treatment comparison group. Taking
into account the seriously adverse effects seen in
short-term drug studies (60,62), forceful traction
mobilization and manipulations might be better
choices of treatment in patients with hip OA or hip
disability.
Conclusion
The findings suggest clinically important post-
treatment effects by a compiled physiotherapy pro-
gram including forceful traction mobilizations of-
fered by more hip specialized therapists in patients
with hip disability in primary healthcare. The long-
term effect is not known. Scientists might seek the
normal variation of in vivo hip capsular stiffness in
healthy adults. This is a presupposition for deter-
mining whether therapists are truly able to differ-
entiate between people with normal versus hyper hip
stiffness, and if forceful traction mobilization can
actually reduce hip stiffness. They might also seek
for the force, frequency, and volume of elongation
and relaxation cycles needed to achieve the hyster-
esis effect. Such data might be a basis for RCTs with
larger sample size, further blinding, valid ROM
measurements, known forces in both groups, stan-
dardized information and exercise regimes, more
frequent follow-ups, and longer follow-up periods.
Then, in the future, we might know more about
which part of the treatment protocol is causing the
effect, the effects onset time and the true ES. The
experimental approach seems promising and has
shown no side-effects in this trial.
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